February 9, 2026 · Form 4 insider transaction
Metzger Michael A sold 17,159 shares of SYNDAX PHARMACEUTICALS INC at $21.03 per share, a transaction worth $360.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.